Stock Analysts

Ashland (ASH) Enters into $1.2 Billion Credit Agreement

Ashland Inc. ASH said that it has entered into a new credit agreement with a number of banks that provides for a five-year senior unsecured revolving credit facility in an aggregate amount of $1.2 billion. This includes a $250 million letter of credit sublimit and a $100 million swing line loan sublimit, and a five-year senior unsecured term loan facility in an aggregate principal amount of $1.1 billion. […]

Stock Analysts

Agios Doses First Patient with AG-881 in Early-Stage Study

Agios Pharmaceuticals, Inc. AGIO announced that it has dosed the first patient in a phase I, multi-center, open-label, dose-escalation and expansion study on single agent AG-881, a second generation IDH inhibitor. The study will evaluate the safety, clinical activity, pharmacokinetics and pharmacodynamics of the candidate in patients with advanced solid tumors with an IDH mutation. […]

Stock Analysts

Glaxo, Pfizer Meningitis B Vaccines Get ACIP’s Category B

GlaxoSmithKline plc GSK and Pfizer PFE both received an expanded recommendation from the U.S. Centers for Disease Control Advisory Committee on Immunization Practices (ACIP) for their meningococcal group B vaccines, Bexsero and Trumenba, respectively. However, the committee’s opinion fell short of recommending a routine use of the vaccines in patients, thereby leaving the decision to vaccinate against meningococcal group B to qualified health care professionals, following an individual patient risk assessment […]

Mergers & Acquisitions

Ontario Teachers’ to expand ownership of BluEarth Renewables

Ontario Teachers’ to expand ownership of BluEarth Renewables PR Newswire TORONTO, June 25, 2015 TORONTO , June 25, 2015 /PRNewswire/ – Ontario Teachers’ Pension Plan (Teachers’) today announced the acquisition of the outstanding shares of BluEarth Renewables Inc. (BluEarth) owned by ARC Energy Fund 6, advised by ARC Financial Corp. (ARC), and minority shareholders, with BluEarth management and employees maintaining an ownership stake. […]

Stock Analysts

Emerson’s Process Management Products Gain Certification

Premium industrial goods company Emerson Electric Co. EMR continues to drive commercial growth on the back of strategic innovations. Recently, the company’s Process Management business unit announced that its Rosemount 8800 Vortex Flowmeters and Micro Motion Coriolis has secured the certification of B31.3 Process Piping design standard as well as American Society of Mechanical Engineers (‘ASME’) B31.1 Power Piping design standard. […]

Stock Analysts

Philips Improves Ultrasound Experience with Lumify Launch

Premium consumer goods company Koninklijke Philips N.V PHG recently equipped the healthcare sector with ‘Lumify’, its new App-Based Ultrasound device. The product’s cloud-enabled system and tablet technology would offer greater mobility, connectivity and flexibility during any ultrasound process. […]

Stock Analysts

Transition Therapeutics Tanks on Alzheimer’s Disease Data

Transition Therapeutics Inc. ’s TTHI shares plunged 74.1% immediately after the company reported that one of its lead pipeline candidates, ELND005, failed to achieve the primary endpoint in a phase II/III study. ELND005 is being evaluated for the treatment of patients suffering from mild-to-severe Alzheimer’s disease (AD), who experience at least moderate levels of agitation/aggression […]

Stock Analysts

Baxter Provides Update on BAX 335 Trial Ahead of Spin-Off

Shares of Baxter International Inc. BAX gained 1.37% (97 cents) to close at $71.64 on June 24, following an update on an ongoing trial that intends to evaluate the safety and optimal dosing level of BAX 335 – an investigational factor IX (FIX) gene therapy used to treat hemophilia B. Hemophilia B (or Christmas disease) is a rare genetic disorder in which an individual’s blood does not clot properly […]